Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Nov 20, 2014
5 / 5 (2) | 0
A breakthrough in understanding of a rare form of blood cancer could lead to significant improvements in treatment for patients. Scientists from the University of Southampton announced their findings at a ...
Dec 09, 2014
5 / 5 (1) | 0